Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Apollo Endosurgery Inc - Key Facts

Apollo Endosurgery Inc - Key Employees

Apollo Endosurgery Inc - Key Employee Biographies

Apollo Endosurgery Inc - Major Products and Services

Apollo Endosurgery Inc - History

Apollo Endosurgery Inc - Company Statement

Apollo Endosurgery Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Apollo Endosurgery Inc - Business Description

Product Category: Endo-Bariatric

Overview

Performance

Product Category: Other

Performance

Product Category: Surgical

Overview

Performance

Geographical Segment: Outside the US

Performance

Geographical Segment: The US

Performance

R&D Overview

Apollo Endosurgery Inc - Corporate Strategy

Apollo Endosurgery Inc - SWOT Analysis

SWOT Analysis - Overview

Apollo Endosurgery Inc - Strengths

Apollo Endosurgery Inc - Weaknesses

Apollo Endosurgery Inc - Opportunities

Apollo Endosurgery Inc - Threats

Apollo Endosurgery Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Apollo Endosurgery Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Apollo Endosurgery Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 02, 2019: Apollo Endosurgery reports first quarter 2019 results

Mar 26, 2019: Apollo Endosurgery names John Barr to Board of Directors

Mar 18, 2019: Apollo Endosurgery reports fourth quarter and full year 2018 results

Nov 08, 2018: Apollo Endosurgery reports third quarter 2018 results

Aug 08, 2018: Apollo Endosurgery reports second quarter 2018 results

Jun 25, 2018: Two diabetes medications don’t slow progression of type 2 diabetes in youth

May 31, 2018: Apollo Endosurgery Appoints Dr. Julie Shimer to Board of Directors

May 03, 2018: Apollo Endosurgery Reports First Quarter 2018 Results

Mar 01, 2018: Apollo Endosurgery Reports Fourth Quarter and Full Year 2017 Results

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

Apollo Endosurgery Inc (APEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Apollo Endosurgery Inc (Apollo Endosurgery) formerly Lpath Inc is a medical technology company that designs, develops and commercializes medical devices used for the treatment of obesity. The company’s product portfolio comprises endo-bariatric products such as Orbera Intragastric Balloon System; and OverStitch endoscopic suturing system. These non-surgical interventional devices are also used in procedures that address or repair a variety of gastrointestinal defects. Apollo Endosurgery's products serve bariatric surgeons and gastroenterologists in providing interventional therapy for obesity and associated co-morbidities; closure of acute perforations and chronic fistulas; tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon; inadvertent perforation of the GI tract; and in the treatment of swallowing disorders and also to suture in place esophageal stents for preventing their migration. It has a manufacturing facility in the Coyol Free Trade Zone in Alajuela, Costa Rica. Apollo Endosurgery is headquartered in Austin, Texas, the US.

Apollo Endosurgery Inc Key Recent Developments

May 02,2019: Apollo Endosurgery reports first quarter 2019 results
Mar 26,2019: Apollo Endosurgery names John Barr to Board of Directors
Mar 18,2019: Apollo Endosurgery reports fourth quarter and full year 2018 results
Nov 08,2018: Apollo Endosurgery reports third quarter 2018 results
Aug 08,2018: Apollo Endosurgery reports second quarter 2018 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company